Cravatex Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, sales was INR 3,328.22 million compared to INR 2,802.85 million a year ago. Revenue was INR 3,368.41 million compared to INR 2,849.55 million a year ago. Net loss was INR 302.89 million compared to INR 170.44 million a year ago. Basic loss per share from continuing operations was INR 117.21 compared to INR 65.96 a year ago. Diluted loss per share from continuing operations was INR 117.21 compared to INR 65.96 a year ago.